Theriva Biologics Inc. (TOVX) support and resistance · rev $300.0K
Theriva Biologics Inc. (TOVX) is a biotechnology company listed on NYSE MKT.
This page maps Theriva Biologics Inc. (TOVX) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported TOVX revenue for 2026-06-30 was $300.0K. Net income was -$5.3M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. TOVX currently screens at market cap $12.4M.
TOVX currently screens at market cap $12.4M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new TOVX 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the TOVX quote page for the session range and the stock page for the full model.
Not investment advice.